Zobrazeno 1 - 10
of 4 972
pro vyhledávání: '"nab-Paclitaxel"'
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background The cost-effectiveness of NALIRIFOX as a potential new standard of care for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) has yet to be established. Our objective was to evaluate the cost-effectiveness of NALIR
Externí odkaz:
https://doaj.org/article/a70ede166a6d48b9b980f90901bb03fe
Autor:
Alfredo Budillon, Alessandra Leone, Eugenia Passaro, Lucrezia Silvestro, Francesca Foschini, Federica Iannelli, Maria Serena Roca, Marina Macchini, Francesca Bruzzese, Maria Laura Garcia Bermejo, Mercedes Rodriguez Garrote, Giampaolo Tortora, Michele Milella, Michele Reni, Claudia Fuchs, Eve Hewitt, Christine Kubiak, Elena Di Gennaro, Diana Giannarelli, Antonio Avallone
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Metastatic pancreatic ductal adenocarcinoma (mPDAC) patients have very poor prognosis highlighting the urgent need of novel treatments. In this regard, repurposing non-oncology already-approved drugs might be an attractive strateg
Externí odkaz:
https://doaj.org/article/f6149487f29c497eb35e762b7f745421
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 51, Iss 9, Pp 779-783 (2024)
ObjectiveTo compare the efficacy of trastuzumab plus pertuzumab (HP) combined with either nab-paclitaxel plus carboplatin or docetaxel plus carboplatin as neoadjuvant therapy for HER2-positive breast cancer in real-world clinical practice. MethodsCli
Externí odkaz:
https://doaj.org/article/0bb8f6ebb60b4cd0aed449714f47c2f7
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 1065-1076 (2024)
Eetu Heervä,1 Vesa Väliaho,1 Heidi Nurmi,1 Elina Lietzen,2 Annika Ålgars,1 Saila Kauhanen2 1Department of Oncology, Turku University Hospital and University of Turku, Turku, Finland; 2Department of Digestive Surgery, Turku University Hospital and
Externí odkaz:
https://doaj.org/article/bc7eeceeae8a4d1d8e7963b19898019b
Autor:
Soumen Saha, Samagya Banskota, Parisa Yousefpour, Jeffrey L. Schaal, Nikita Zakharov, Jianqiao Liu, Michael Dzuricky, Ziwei He, Stefan Roberts, Xinghai Li, Ashutosh Chilkoti
Publikováno v:
Small Science, Vol 4, Iss 11, Pp n/a-n/a (2024)
Nab‐paclitaxel (Abraxane), an albumin‐bound solvent‐free paclitaxel (PTX) formulation that takes advantage of the endogenous albumin transport pathway, is the current gold standard for treatment of solid tumors with PTX. However, nab‐paclitax
Externí odkaz:
https://doaj.org/article/f24ec2aa4c224b659763f6bcc87b8c31
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse event observed in patients receiving paclitaxel, associated with initial pathological changes in the peripheral nervous system, i.e., distal nerves and dorsal ro
Externí odkaz:
https://doaj.org/article/a16c4cda158a43fa82978a0bfe8c6295
Autor:
Kellie L. Bodeker, Brian J. Smith, Daniel J. Berg, Chandrikha Chandrasekharan, Saima Sharif, Naomi Fei, Sandy Vollstedt, Heather Brown, Meghan Chandler, Amanda Lorack, Stacy McMichael, Jared Wulfekuhle, Brett A. Wagner, Garry R. Buettner, Bryan G. Allen, Joseph M. Caster, Barbara Dion, Mandana Kamgar, John M. Buatti, Joseph J. Cullen
Publikováno v:
Redox Biology, Vol 77, Iss , Pp 103375- (2024)
Background: Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) have poor 5-year survival. Pharmacological ascorbate (P-AscH-, high dose, intravenous, vitamin C) has shown promise as an adjunct to chemotherapy. We hypothesized adding P-A
Externí odkaz:
https://doaj.org/article/7a718d95f6c446c69fd37ed4334b67e1
Publikováno v:
Gynecologic Oncology Reports, Vol 55, Iss , Pp 101475- (2024)
The goal of this study was to assess the safety of nab-paclitaxel in patients with ovarian cancer or endometrial cancer who had an allergic reaction to paclitaxel. We performed a retrospective review of patients with endometrial cancer or ovarian can
Externí odkaz:
https://doaj.org/article/b49a38d04a8741208e2a1a52b676d4a6
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Evaluate the efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in treating locally advanced cervical cancer (LACC). Methods Retrospective data was collected from LACC patients who were treated at
Externí odkaz:
https://doaj.org/article/4bd6f1f4f16f4b66b84116d8e448109e
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 1431-1437 (2024)
Lele Yu, Binhai Zhang, Hu Wan Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People’s Hospital, Hangzhou, Zhejiang, 310023, People’s Republic of ChinaCorrespondence: Hu Wan, Email yll8024@126.comIntroduction: Kaposi
Externí odkaz:
https://doaj.org/article/9a7880bda1b64f0e9dab06990725a4bf